Schizophreniform Disorder: Clinical Trials

75 trials for Schizophreniform Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

53 completed, 9 terminated, 7 unknown, 4 recruiting. 28 Not applicable, 19 Phase 4, 9 Phase 2, 7 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable28Completed 21, Recruiting 3, Terminated 2, Unknown 2
Phase 419Completed 11, Terminated 5, Unknown 2, Withdrawn 1
Phase 29Completed 7, Terminated 1, Unknown 1
Phase 17Completed 5, Not yet recruiting 1, Unknown 1
Phase 35Completed 4, Recruiting 1

Follow Schizophreniform Disorder: new trials by email Literature Review of Schizophreniform Disorder trials Research Report on Schizophreniform Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia
Brexpiprazole, Cariprazine, [11C] PHNO - Schizoaffective Disorder, Schizophreniform Disorder
Phase 1Not yet recruitingNew York State Psychiatric Institute1002026-12-012026-07-20
Cognitive Strategies in Early Psychosis 2
Modafinil, D-serine solution, Placebo - Psychosis, Schizophrenia Disorder
Phase 3RecruitingUniversity of Minnesota242026-07-172026-07-23
MicroRNAs as Biomarkers in First Episode Schizophrenia
Plasma NDE miRNA Sequencing, Whole Genome Sequencing - Schizophrenia Disorder, Schizophreniform Disorder
Not applicableRecruitingNorthwell Health1602026-07-012026-07-14
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
FEEL GOOD, Treatment as Usual (TAU) - Delusional Disorder, Brief Psychotic Disorder
Not applicableRecruitingStephanie Mehl2522026-05-272026-09-22
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
Cognitive training, Aerobic Exercise Program, Moderated Online Social Therapy (MOST) - Schizophrenia, Schizophreniform Disorder
Not applicableRecruitingUniversity of California, Los Angeles1002023-05-232026-08-04
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia
Minocycline - Schizophrenia, Schizoaffective Disorder
Phase 1UnknownPakistan Institute of Living and Learning602022-08-302022-04-29
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
N-acetylcysteine (NAC), Placebo, Tryptophan - Schizophrenia, Schizoaffective Disorder
Phase 1 / Phase 2CompletedUniversity of Maryland, Baltimore882020-01-202026-02-11
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Aripiprazole Lauroxil, ARI-ORAL, AL-NCD - Schizophrenia, Schizoaffective Disorder, Depressive Type
Phase 4TerminatedUniversity of California, Los Angeles152019-12-162023-11-28
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life
Exercise Intervention- PACE-Life - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedUniversity of North Carolina, Chapel Hill172018-12-062020-09-21
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
ALKS 3831 - Schizophrenia, Schizophreniform Disorder
Phase 3CompletedAlkermes, Inc.5232017-06-152024-09-26
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
Cognitive Training, Aerobic Exercise, Case management and supportive psychotherapy - Schizophrenia, Schizophreniform Disorder
Not applicableCompletedUniversity of California, Los Angeles1002016-10-132023-11-27
Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia
Clonazepam, Placebo - Schizophrenia, Schizoaffective Disorder
Phase 4WithdrawnPalo Alto Veterans Institute for Research2016-10-012018-04-05
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
Raloxifene, Placebo - Schizophrenia, Schizoaffective Disorder
Phase 3CompletedIris Sommer1102016-08-012021-10-08
RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)
Community-based rehabilitation, Facility based care - Schizophrenia Spectrum Disorder, Schizophrenia
Not applicableCompletedLondon School of Hygiene and Tropical Medicine1662015-09-012017-05-10
Electronic Cigarettes in Smokers With Mental Illness
disposable electronic cigarettes - Schizophrenia, Schizophreniform Disorder
Not applicableCompletedKing's College London502014-09-242017-05-16
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
PGx testing guided treatment (PGT) - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedNorthwell Health362014-07-102018-01-24
Prednisolone Addition for Patients With Recent-onset Psychotic Disorder
Prednisolone, Placebo Oral Tablet - Schizophrenia, Schizoaffective Disorder
Phase 4TerminatedUMC Utrecht422014-07-012019-06-24
Integrated Metacognitive Therapy in First Episode Psychosis
Integrated Metacognitive Therapy, Treatment as Usual - Schizophrenia, Schizophreniform Disorder
Not applicableCompletedIndiana University202014-05-012018-03-29
rTMS in First Episode Psychosis
rTMS, Sham Comparator - Schizophrenia, Schizophreniform Disorder
Not applicableCompletedIndiana University202014-04-302023-04-19
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia
CBT-E, Treatment as Usual - Schizophrenia, Delusional Disorder
Not applicableCompletedPhilipps University Marburg642014-01-012020-03-04

Showing 20 of 75. Sign in to see all of them.

Narrower conditions

Psychotic Disorders (75)  ·  Schizophrenia (74)  ·  Mental Disorders (17)  ·  Bipolar Disorder (10)  ·  Schizophrenia, Paranoid (7)  ·  Depressive Disorder, Major (4)  ·  Autism Spectrum Disorder (3)  ·  Cognition Disorders (3)  ·  Mood Disorders (3)  ·  Weight Gain (3)  ·  Autistic Disorder (2)  ·  Body Weight (2)  ·  Emotional Regulation (2)  ·  Motor Activity (2)  ·  Smoking (2)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (75)  ·  Mental Disorders (58)  ·  Bipolar and Related Disorders (10)  ·  Mood Disorders (9)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Behavior (7)  ·  Signs and Symptoms (7)  ·  Body Weight (4)  ·  Body Weight Changes (4)  ·  Neurodevelopmental Disorders (4)  ·  Child Development Disorders, Pervasive (3)  ·  Depressive Disorder (3)  ·  Neurocognitive Disorders (3)  ·  Nervous System Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

Risperidone (8)  ·  Olanzapine (7)  ·  Therapeutics (5)  ·  Raloxifene Hydrochloride (4)  ·  Amisulpride (3)  ·  Aripiprazole (3)  ·  Cognitive Remediation (3)  ·  Cognitive Training (3)  ·  Simvastatin (3)  ·  Case Management (2)  ·  Cognitive Behavioral Therapy (2)  ·  Estradiol (2)  ·  Exercise (2)  ·  Lactose (2)  ·  Modafinil (2)

Sponsors

Centre for Addiction and Mental Health (5)  ·  University of Maryland, Baltimore (5)  ·  University of North Carolina, Chapel Hill (5)  ·  Northwell Health (4)  ·  Pakistan Institute of Living and Learning (4)  ·  University of California, Los Angeles (4)  ·  New York State Psychiatric Institute (3)  ·  The Alfred (3)  ·  AstraZeneca (2)  ·  Indiana University (2)  ·  Iris Sommer (2)  ·  Janssen-Cilag, S.A. (2)  ·  NYU Langone Health (2)  ·  Alkermes, Inc. (1)  ·  Bayside Health (1)

Countries

United States (35)  ·  Germany (8)  ·  Canada (7)  ·  Australia (5)  ·  Israel (4)  ·  Netherlands (4)  ·  Pakistan (4)  ·  Denmark (3)  ·  United Kingdom (3)  ·  Austria (2)  ·  Belgium (2)  ·  Bulgaria (2)  ·  Italy (2)  ·  Poland (2)  ·  Russia (2)

Top investigators

Jayashri Kulkarni, MBBS, MPM, FRANZCP, PhD (2)  ·  Karen A Graham, MSc MD (2)  ·  L.Elliot Hong, M.D. (2)  ·  Abebaw Fekadu (1)  ·  Alan Breier, MD (1)  ·  Anatoly Kreinin, MD, PhD (1)  ·  Andreas Bechdolf, PD Dr. (1)  ·  Andreas Bechdolf, Prof. Dr. (1)  ·  Andrew Cutler, MD (1)  ·  Ann McNeill, BSc, PhD, Prof (1)  ·  Ariel Graff, MD (1)  ·  Ariel Graff-Guerrero, MD, PhD (1)  ·  Ariel Graff-Guerrero, MD,PhD (1)

Results publications

PMID 10332540, PMID 10849191, PMID 18678800, PMID 19890258, PMID 20812791, PMID 21810630, PMID 21813073, PMID 22204569, PMID 23782463, PMID 23805859, PMID 24062154, PMID 24062155, PMID 24996765, PMID 25188752, PMID 25563714, PMID 25727536, PMID 25830446, PMID 26072311, PMID 26481174, PMID 26674520, PMID 26911397, PMID 27342215, PMID 27438995, PMID 27557949, PMID 28086010, PMID 28427286, PMID 28693614, PMID 28778554, PMID 28945118, PMID 29444349, PMID 29485988, PMID 29986786, PMID 30115598, PMID 30139553, PMID 30241990, PMID 30542300, PMID 31026764, PMID 31084291, PMID 31415936, PMID 31708810, PMID 31814102, PMID 32052566, PMID 32507378, PMID 33493778, PMID 33536130, PMID 33711681, PMID 33814546, PMID 33838518, PMID 34078485, PMID 35026597

NIH funding

2015 (1), K23MH077653 (1), P50MH119569 (1), R01DA027680 (1), R01DK093924 (1), R01MH084900 (1), R01MH085646 (1), R01MH130848 (1), R01MH139651 (1), R34MH102529 (1), R34MH111852 (1)